Li, S., Fu, J., Liu, G., Ma, H., Mapara, M., Marcireau, C., & Lentzsch, S. (2023). P-200 MAP4K2 inhibition reinforces sensitivity to iberdomide in RAS-mutated MM through a CRBN-independent mechanism. Clinical Lymphoma Myeloma and Leukemia, 23, S145–S146. https://doi.org/10.1016/s2152-2650(23)01818-9
Subjects:
Calcineurin-NFAT Signaling in Transcriptional Regulation
(OpenAlex Topic)
Chromatin Remodeling in Cancer and Development
(OpenAlex Topic)
Targeted Protein Degradation in Biomedical Research
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)01818-9
Publication Date:
Data Source:
OpenAlex
Source Link: